Ruxolitinib phosphate is under clinical development by Novartis and currently in Phase II for Coronavirus Disease 2019 (COVID-19).

Ruxolitinib phosphate is under clinical development by Incyte and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Cytokine Release Syndrome.

A newly released Senate intelligence report has criticized the Central Intelligence Agency (CIA) for its handling of cases related to the mysterious health condition known as Havana Syndrome.

The ICOD (Improving Condition in Down syndrome) project, a pioneering study in addressing the cognitive difficulties associated with Down syndrome, has demonstrated the safety of treatment with ...

Bronchiolitis obliterans syndrome (BOS) is a clinical manifestation of BO in ... currently evaluated in clinical trials and have the potential to be applied in the treatment of various types of BOS.

Rapid and aggressive treatment of respiratory infections is fundamental to the management of this disorder. After stabilization, a pulmonary rehabilitation program with an ongoing home exercise ...

Dec. 19, 2024 — A team has discovered a new communication pathway between the gut and lung. Their findings highlight how a little-known member of the gut microbiome reshapes the lung immune ...